Please login to the form below

Not currently logged in
Email:
Password:

More foot and mouth disease at Merial Animal Health

A new outbreak of foot and mouth disease is reported at the facility run by Merial Animal Health at the Pirbright scientific research centre

A new outbreak of foot and mouth disease has been reported at the facility run by Merial Animal Health at the Pirbright scientific research centre.

Operations at the plant were immediately stopped when the leak was detected and citric acid was used to disinfect any traces of virus which might have leaked from waste pipes.

It has been confirmed that the virus, which leaked from a faulty valve has been contained within the drainage system, meaning that contamination to farm animals is very unlikely.

Hilary Benn, Rural Affairs Secretary, revealed in the House of Commons that there had been no release of the virus to the environment.

Merial informed the Department for Environment, Food and Rural Affairs about the incident on 20 November and the company's operating licence has been again suspended.

Previously, the previous outbreak was traced back to the UK government-run laboratory, while Merial was cleared of any involvement.

Merial Animal health was formed in a joint venture between Rhone Merieux (now sanofi-aventis) and Merck, Sharpe and Dohme AgVet, a division of US-based pharmaceutical company, Merck & Co.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics